Avenda Health

SCOPE
Create a soft tissue ablation system for targeted prostate cancer treatment using laser energy channeled through multiple catheters guided into a small location. Enable real-time active cooling, thermal monitoring, and laser control in the O.R.
OUTCOME
The system achieved 510(k) approval in two years and had 100% success in patient studies, improving patient quality of life and eliminating the need for rehabilitation after treatment. The Avenda system is the first FDA-approved prostate cancer treatment in 40 years.

Meet Our Team

Get in touch with us today to see how we can help you achieve your goals.